132 related articles for article (PubMed ID: 35478361)
1. ZEB1 expression is frequently detected in undifferentiated and de-differentiated carcinomas, but is not specific among endometrial carcinomas.
Kihara A; Amano Y; Fukushima N; Fujiwara H; Niki T
Histopathology; 2022 Jul; 81(1):108-118. PubMed ID: 35478361
[TBL] [Abstract][Full Text] [Related]
2. Role of epithelial-mesenchymal transition factors in the histogenesis of uterine carcinomas.
Franceschi T; Durieux E; Morel AP; de Saint Hilaire P; Ray-Coquard I; Puisieux A; Devouassoux-Shisheboran M
Virchows Arch; 2019 Jul; 475(1):85-94. PubMed ID: 30739164
[TBL] [Abstract][Full Text] [Related]
3. ZEB1 overexpression associated with E-cadherin and microRNA-200 downregulation is characteristic of undifferentiated endometrial carcinoma.
Romero-Pérez L; López-García MÁ; Díaz-Martín J; Biscuola M; Castilla MÁ; Tafe LJ; Garg K; Oliva E; Matias-Guiu X; Soslow RA; Palacios J
Mod Pathol; 2013 Nov; 26(11):1514-24. PubMed ID: 23743934
[TBL] [Abstract][Full Text] [Related]
4. Androgen Receptor Immunohistochemical Expression in Undifferentiated/Dedifferentiated Endometrial Carcinoma.
Cao J; Hacking S; Chavarria-Bernal HD; Bhuiya TA; Khutti S
Int J Gynecol Pathol; 2022 Jan; 41(1):28-34. PubMed ID: 33399351
[TBL] [Abstract][Full Text] [Related]
5. Expression of neuroendocrine markers in non-neuroendocrine endometrial carcinomas.
Moritz AW; Schlumbrecht MP; Nadji M; Pinto A
Pathology; 2019 Jun; 51(4):369-374. PubMed ID: 31040050
[TBL] [Abstract][Full Text] [Related]
6. Frequent loss of claudin-4 expression in dedifferentiated and undifferentiated endometrial carcinomas.
Tessier-Cloutier B; Soslow RA; Stewart CJR; Köbel M; Lee CH
Histopathology; 2018 Aug; 73(2):299-305. PubMed ID: 29671892
[TBL] [Abstract][Full Text] [Related]
7. Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms.
Tafe LJ; Garg K; Chew I; Tornos C; Soslow RA
Mod Pathol; 2010 Jun; 23(6):781-9. PubMed ID: 20305618
[TBL] [Abstract][Full Text] [Related]
8. ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease.
Singh M; Spoelstra NS; Jean A; Howe E; Torkko KC; Clark HR; Darling DS; Shroyer KR; Horwitz KB; Broaddus RR; Richer JK
Mod Pathol; 2008 Jul; 21(7):912-23. PubMed ID: 18487993
[TBL] [Abstract][Full Text] [Related]
9. Dedifferentiated endometrial carcinomas with neuroendocrine features: a clinicopathologic, immunohistochemical, and molecular genetic study.
Espinosa I; De Leo A; D'Angelo E; Rosa-Rosa JM; Corominas M; Gonzalez A; Palacios J; Prat J
Hum Pathol; 2018 Feb; 72():100-106. PubMed ID: 29133142
[TBL] [Abstract][Full Text] [Related]
10. High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations.
Murali R; Davidson B; Fadare O; Carlson JA; Crum CP; Gilks CB; Irving JA; Malpica A; Matias-Guiu X; McCluggage WG; Mittal K; Oliva E; Parkash V; Rutgers JKL; Staats PN; Stewart CJR; Tornos C; Soslow RA
Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S40-S63. PubMed ID: 30550483
[TBL] [Abstract][Full Text] [Related]
11. [Un- and dedifferentiated endometrial carcinoma : A rare entity with a wide range of differential diagnosis].
Höhn AK; Brambs CE; Opitz S; Erber R; Hartmann A; Horn LC
Pathologe; 2019 Nov; 40(6):609-618. PubMed ID: 31578630
[TBL] [Abstract][Full Text] [Related]
12. BRG1, INI1, and ARID1B Deficiency in Endometrial Carcinoma: A Clinicopathologic and Immunohistochemical Analysis of a Large Series From a Single Institution.
Kihara A; Amano Y; Matsubara D; Fukushima N; Fujiwara H; Niki T
Am J Surg Pathol; 2020 Dec; 44(12):1712-1724. PubMed ID: 32910019
[TBL] [Abstract][Full Text] [Related]
13. The diagnostic utility of zinc E-box 1 (ZEB1) transcription factor for identification of pulmonary sarcomatoid carcinoma in cytologic and surgical specimens.
Viswanathan K; Siddiqui MT; Borczuk AC
J Am Soc Cytopathol; 2020; 9(1):55-61. PubMed ID: 31677963
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical characterization of prototypical endometrial clear cell carcinoma--diagnostic utility of HNF-1β and oestrogen receptor.
Hoang LN; Han G; McConechy M; Lau S; Chow C; Gilks CB; Huntsman DG; Köbel M; Lee CH
Histopathology; 2014 Mar; 64(4):585-96. PubMed ID: 24103020
[TBL] [Abstract][Full Text] [Related]
15. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic utility of hepatocyte nuclear factor 1-beta immunoreactivity in endometrial carcinomas: lack of specificity for endometrial clear cell carcinoma.
Fadare O; Liang SX
Appl Immunohistochem Mol Morphol; 2012 Dec; 20(6):580-7. PubMed ID: 22495362
[TBL] [Abstract][Full Text] [Related]
17. Endometrial neuroendocrine carcinoma and undifferentiated carcinoma are distinct entities with overlap in neuroendocrine marker expression.
Tessier-Cloutier B; Kang EY; Alex D; Stewart CJR; McCluggage WG; Köbel M; Lee CH
Histopathology; 2022 Jul; 81(1):44-54. PubMed ID: 35394077
[TBL] [Abstract][Full Text] [Related]
18. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
Zheng W; Yi X; Fadare O; Liang SX; Martel M; Schwartz PE; Jiang Z
Am J Surg Pathol; 2008 Feb; 32(2):304-15. PubMed ID: 18223334
[TBL] [Abstract][Full Text] [Related]
19. The transcription factor ZEB1 is aberrantly expressed in aggressive uterine cancers.
Spoelstra NS; Manning NG; Higashi Y; Darling D; Singh M; Shroyer KR; Broaddus RR; Horwitz KB; Richer JK
Cancer Res; 2006 Apr; 66(7):3893-902. PubMed ID: 16585218
[TBL] [Abstract][Full Text] [Related]
20. Mesonephric-like Endometrial Carcinoma: Results From Immunohistochemical Screening of 300 Endometrial Carcinomas and Carcinosarcomas for This Often Overlooked and Potentially Aggressive Entity.
Mills AM; Jenkins TM; Howitt BE; Fan J; Ring KL; Cook I
Am J Surg Pathol; 2022 Jul; 46(7):921-932. PubMed ID: 35195579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
